Katherine Schreiber

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Google:
"Katherine Schreiber"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bailus BJ, Scheeler SM, Simons J, et al. (2021) Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels. Autophagy. 1-22
Powers SK, Holehouse AS, Korasick DA, et al. (2019) Nucleo-cytoplasmic Partitioning of ARF Proteins Controls Auxin Responses in Arabidopsis thaliana. Molecular Cell
Schreiber KH, Arriola Apelo SI, Yu D, et al. (2019) A novel rapamycin analog is highly selective for mTORC1 in vivo. Nature Communications. 10: 3194
Haller S, Kapuria S, Riley RR, et al. (2017) mTORC1 Activation during Repeated Regeneration Impairs Somatic Stem Cell Maintenance. Cell Stem Cell. 21: 806-818.e5
Schreiber KH, Ortiz D, Academia EC, et al. (2015) Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins. Aging Cell. 14: 265-73
O'Leary MN, Schreiber KH, Zhang Y, et al. (2013) The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1. Plos Genetics. 9: e1003708
Garelick MG, Mackay VL, Yanagida A, et al. (2013) Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo. Cell Cycle (Georgetown, Tex.). 12: 2493-504
Schreiber KH, Kennedy BK. (2013) When lamins go bad: nuclear structure and disease. Cell. 152: 1365-75
Ramos FJ, Chen SC, Garelick MG, et al. (2012) Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Science Translational Medicine. 4: 144ra103
See more...